Complementary Healthcare Analysis - 2019-09-06
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
| Top Gainers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Mallinckrodt plc (MNK) | 158.81M | 1.75 | 10.06% | 4,160,993 | |
| Endo International plc (ENDP) | 554.55M | 2.71 | 14.83% | 2,605,580 | |
| Lannett Company, Inc. (LCI) | 397.76M | 12.39 | 8.49% | 1,208,560 | |
| Agile Therapeutics, Inc. (AGRX) | 72.28M | 1.35 | 7.72% | 971,960 | |
| OrganiGram Holdings Inc. (OGI) | 507.08M | 5.06 | 6.16% | 580,634 | |
| Top Losers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Edesa Biotech, Inc. (EDSA) | 42.76M | 5.45 | -8.86% | 481,847 | |
| Sunesis Pharmaceuticals, Inc. (SNSS) | 114.17M | 0.98 | -5.77% | 357,084 | |
| High volume stocks reaching new highs | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Lannett Company, Inc. (LCI) | 397.76M | 12.53 | 9.72% | 1,259,662 | |
| DURECT Corporation (DRRX) | 305.21M | 1.85 | 11.45% | 475,327 | |
| High volume stocks reaching new lows | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Zafgen, Inc. (ZFGN) | 26.64M | 0.67 | -4.31% | 566,044 | |
| Assertio Therapeutics, Inc. (ASRT) | 86.71M | 1.27 | -3.79% | 371,562 | |
| Major Analyst Upgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| HCA Healthcare (HCA) | Underperform | Neutral | Bank of America | $125.68 | $137.00 |
| Major Analyst Downgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| Aclaris Therapeutics (ACRS) | Outperform | Market Perform | JMP Securities | $1.00 | |
| MEDNAX (MD) | Neutral | Underperform | Bank of America | $20.52 | |
| Zafgen (ZFGN) | Outperform | Neutral | Wedbush | $0.67 | $0.78 |
| Major Insider Buys | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Aileron Therapeutics Inc (ALRN) | Von Rickenbach Josef H | Dir | $0.71 | 23225 | +$16,583 |
| Altimmune, Inc. (ALT) | Garg Vipin K | Pres, CEO | $2.10 | 20000 | +$42,000 |
| Elanco Animal Health Inc (ELAN) | Simmons Jeffrey N | Pres, CEO, Dir | $26.55 | 75750 | +$2,011,163 |
| Young Todd S. | $26.57 | 10000 | +$265,700 | ||
| Lannett Co Inc (LCI) | Lepore Patrick G | Dir | $9.82 | 25000 | +$245,500 |
| Organogenesis Holdings Inc. (ORGO) | Avista Capital Managing Member Iv, LLC | Dir, 10% | $4.84 | 577600 | +$2,797,551 |
| Katz Michael W | 10% | $4.50 | 10000 | +$44,975 | |
| Leibowitz Arthur S | Dir | $4.20 | 5000 | +$21,000 | |
| Mackie Wayne D | Dir | $4.47 | 82000 | +$366,211 | |
| Nussdorf Glenn H | Dir, 10% | $4.50 | 105100 | +$473,209 | |
| Progenics Pharmaceuticals Inc (PGNX) | Velan Capital, L.P. | $4.45 | 521038 | +$2,317,446 | |
| Major Insider Sells | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Amarin Corp Plcuk (AMRN) | Ekman Lars | Dir | $15.01 | -91016 | -$1,365,722 |
| Beigene, Ltd. (BGNE) | Huang Jane | CMO, Hematology | $144.03 | -2944 | -$424,030 |
| Cara Therapeutics, Inc. (CARA) | Chalmers Derek T | Pres, CEO | $23.26 | -5000 | -$116,300 |
| Ives Jeffrey L. | Dir | $23.31 | -2500 | -$58,275 | |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R, D | $22.92 | -20000 | -$458,400 | |
| Deciphera Pharmaceuticals, Inc. (DCPH) | Taylor Michael Douglas | Dir | $36.26 | -7500 | -$271,975 |
| Homology Medicines, Inc. (FIXX) | Seymour Albert | Chief Scientific Officer | $18.74 | -9300 | -$174,284 |
| Smith W Bradford | CFO, Treasurer, Secretary | $18.74 | -6000 | -$112,419 | |
| Tzianabos Arthur | Pres, CEO | $18.75 | -12500 | -$234,320 | |
| Myokardia Inc (MYOK) | Gianakakos Anastasios | Pres, CEO | $52.15 | -4000 | -$208,585 |
| Puma Biotechnology, Inc. (PBYI) | Bryce Richard Paul | $10.11 | -95 | -$960 | |
| Tricida, Inc. (TCDA) | Lockey Claire | Chief Dev. Officer, SVP | $33.76 | -10000 | -$337,627 |
| Urogen Pharma Ltd. (URGN) | Schoenberg Mark | Chief Medical Officer | $33.92 | -343 | -$11,635 |
| Y-Mabs Therapeutics, Inc. (YMAB) | Gad Thomas | Pres, COB | $25.77 | -4000 | -$103,081 |
Index Watch
NASDAQ Health CareINDEXNASDAQ: IXHC
iShares NASDAQ Biotechnology Index
NASDAQ: IBB
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.